Yiming Liu

Partner in Charge – Shanghai
Full contact info

Experience

ImmuneOnco Biopharmaceuticals – HK$319 Million IPO

September 5, 2023

Cooley advised ImmuneOnco Biopharmaceuticals, a clinical-stage biotechnology company dedicated to the development of immuno-oncology therapies, on its HK$319 million initial public offering.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado
Eric Blanchard
Partner, New York
Yiying Wang
Associate, Shanghai
Kaiting Yang
Associate, Hong Kong
Yunxiang Xu
Associate, Shanghai
Xiaoyu Xu
Associate, Beijing
Cecilia Bai
Associate , Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Cindy Pan
International Legal Project Manager, Hong Kong
Alex Wu
International Legal Project Manager, Shanghai
Iris Yang
Senior Legal Assistant, Shanghai
Zhengyang Li
Senior Legal Assistant, Hong Kong

Related Practices & Industries

Laekna Announces Largest 18A IPO Year to Date at HK$791 Million

June 29, 2023

Cooley advised China International Capital Corporation Hong Kong Securities Limited (CICC) and other underwriters on Laekna’s HK$791 million (US$101 million) initial public offering of 63,728,000 shares on the Hong Kong Stock Exchange, the largest 18A offering year to date.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Tonny Yu
Associate, Hong Kong
Xiaoyu Xu
Associate, Beijing
April Wang
Associate, Hong Kong
Cindy Pan
International Legal Project Manager, Hong Kong
Iris Yang
Senior Legal Assistant, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Zhengyang Li
Senior Legal Assistant, Hong Kong

Related Practices & Industries

IMPACT Therapeutics Announces Global License Collaboration Agreement With Eikon

June 14, 2023

Cooley advised IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer innovative drugs based on synthetic lethality on its license and collaboration agreement with Eikon Therapeutics, a biotechnology company.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Xiaoyu Xu
Associate, Beijing
Xiaozhen (Shawn) Yu
Associate, Washington DC
Amanda Pacheco
Associate, Palo Alto
Chen Chen
Associate, Palo Alto

Related Practices & Industries

Zion Pharma Announces Sale of Lead Program to Roche

May 15, 2023

Cooley advised Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, on the acquisition of its lead program, ZN-A-1041, by Roche.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Aaron Pomeroy
Partner, Colorado
David Burns
Special Counsel, Washington DC
Xiaoyu Xu
Associate, Beijing
Amanda Pacheco
Associate, Palo Alto
Chen Chen
Associate, Palo Alto

Related Practices & Industries

Summit Healthcare Closes Business Combination With YS Biopharma

March 20, 2023

Cooley advised Summit Healthcare Acquisition Corp. (Summit Healthcare), a publicly traded special purpose acquisition company, on its business combination with YishengBio Co., Ltd. (YS Biopharma), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of innovative vaccines and therapeutic biologics.

Read more

Related contacts

Will Cai
Partner, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Tim Pitrelli
Partner, Singapore
Steven Holm
Associate, Singapore
Hilda Li
Associate, Hong Kong
Harvey Yao
Associate, Hong Kong
Samantha Zhang
Associate, Singapore
Iris Yang
Senior Legal Assistant, Shanghai
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Los Angeles Santa Monica
Calvin Lee
Associate, New York
View more

Rankings & accolades

IFLR1000 Asia Pacific Rankings: M&A in China - Foreign Firm: Rising Star Partner (2023)

Asian Legal Business (ALB), Thomson Reuters: China Top 15 Capital Markets Lawyers (2022)

Asian Legal Business (ALB), Thomson Reuters: China Top 15 Rising Lawyers (2022)